Ground Breaking Mesothelioma Detection Study Begins


2005-09-20 14:00

Mesothelioma

Libby, MT residents participating in Mesothelioma Applied Research Foundation funded research into Mesothelioma Serum Marker

Exciting new developments using a blood serum marker to detect cancer are being investigated in a longitudinal study in Libby Montana. In a generous and caring humanitarian act, nearly half of Libby Montana residents, many of whom have been exposed to asbestos, have agreed to participate in a long term study to calibrate a newly released test for the detection of mesothelioma. Mesothelioma is a malignant tumor that aggressively invades the mesothelial linings of the lungs, abdomen, heart or testicles. Mesothelial cells produce a number of soluble proteins that can be detected in the blood. Elevated levels of a particular protein called soluble mesothelin related protein (SMRP) appear to be closely tied to the presence of mesothelioma.

In a project funded by the Mesothelioma Applied Research Foundation (MARF), the Center for Asbestos Related Disease in Libby (CARD) will be using blood samples from the community, including healthy residents with asbestos exposure and also those with proven cases of asbestos related disease, to identify the levels of SMRP in the blood.

A test for the presence of SMRP called Mesomark